Antonio Zanotti-Gerosa

USPTO Granted Patents = 24 (Patent Applications = 5)

CIPO Patents = 3 (Patent Applications = 2)

EPO Patents = 11 (Patent Applications = 9)

Average Co-Inventor Count = 4.9

ph-index = 4

Forward Citations = 34(Granted Patents)

Location History:

Cambridge, GB (2001 - 2017)
Cambridgeshire, GB (2019)

Company Filing History:

6 out of 52

Bial-portela Ca & S.a.

patents

6 out of 837

Johnson Matthey Public Limited Company

patents

4 out of 30

Chirotech Technology Limited

Novartis Pharmaceuticals Corporation

Universita′ Degli Studi Di Udine

Janssen Pharmaceutica Nv

where one patent can have more than one assignee

Years Active: 2001-2019

Loading Chart...

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10428098 - Processes for preparing and using ruthenium and osmium complexes (2019-10-01),

2. 10406514 - Process for hydrogenating ketones in the presence of Ru(II) catalysts (2019-09-10),

3. 9643929 - Asymmetric catalytic reduction of oxcarbazepine (2017-05-09),

4. 9416100 - Process for hydrogenating ketones in the presence of Ru(II) catalysts (2016-08-16),

5. 9403766 - Intermediates for producing NEP inhibitors or prodrugs thereof (2016-08-02),

6. 9346745 - Process for producing Aliskiren (2016-05-24),

7. 9227934 - Processes for producing NEP inhibitors or prodrugs thereof (2016-01-05),

8. 9206135 - Asymmetric catalytic reduction of oxcarbazepine (2015-12-08),

9. 9061973 - Processes for producing NEP inhibitors or prodrugs thereof (2015-06-23),

10. 8859815 - Sulphonylated diphenylethylenediamines, method for their preparation and use in transfer hydrogenation catalysis (2014-10-14),

11. 8735583 - Chiral phosphorus compound (2014-05-27),

12. 8680278 - Enantioselective process for preparing a substituted alkanoic acid (2014-03-25),

13. 8580974 - Processes (2013-11-12),

14. 8546571 - Catalytic hydrogenation of ene-carbamates (2013-10-01),

15. 8431741 - Process for the hydrogenation of ketoesters (2013-04-30),

Title: Innovator Spotlight: Antonio Zanotti-Gerosa

Introduction

Antonio Zanotti-Gerosa is a prominent inventor based in Cambridge, GB, recognized for his significant contributions to the field of chemistry. With a remarkable portfolio of 24 patents, Zanotti-Gerosa has established himself as a key figure in the development of advanced chemical processes and complexes.

Latest Patents

Among his latest innovations are two noteworthy patents. The first, titled "Processes for preparing and using ruthenium and osmium complexes," focuses on enhanced methods for synthesizing ruthenium complexes with acetate ligands. This invention promises to improve the efficiency and efficacy of these chemical substances. The second patent, "Process for hydrogenating ketones in the presence of Ru(II) catalysts," details a method for hydrogenating substrates containing carbon-heteroatom double bonds. This innovative process involves the reaction of the substrate with hydrogen gas in the presence of specific hydrogenation catalysts, paving the way for more effective chemical reactions.

Career Highlights

Antonio has worked with reputable companies, including Johnson Matthey Public Limited Company, a global leader in sustainable technologies, and Bial-Portela & Ca, S.A., a well-known player in the pharmaceutical sector. His experience in these prestigious organizations has greatly contributed to his development as a leading inventor in the field.

Collaborations

Throughout his career, Zanotti-Gerosa has collaborated with talented professionals, including Gabriela Alexandra Grasa and Jonathan Medlock. These partnerships demonstrate his commitment to innovation and teamwork in advancing chemical research and application.

Conclusion

Antonio Zanotti-Gerosa exemplifies the spirit of innovation through his pioneering work in the field of chemistry. His contributions, marked by his impressive patent portfolio and collaborative efforts, continue to influence the industry and inspire future generations of inventors.

This text is generated by artificial intelligence and may not be accurate.